Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1

References

• Neurofibromatosis. (1988). Conference statement. National institues of Health Consensus Development Conference. Archives of Neurology, 45(5), 575–578. https://doi.org/10.1001/archneur.1994.00540140115021
   PubMedGoogle Scholar
• Anastasaki, C., Orozco, P., & Gutmann, D. H. (2022). RAS and beyond: The many faces of the neurofibromatosis type 1 protein. Disease Models & Mechanisms, 15(2), dmm049362. https://doi.org/10.1242/dmm.049362
   PubMed Web of Science ®Google Scholar
• Arnold, S. S., Payne, J. M., McArthur, G., North, K. N., & Barton, B. (2020). Profiling the word reading abilities of school-age children with neurofibromatosis type 1. Journal of the International Neuropsychological Society, 27(5), 484–496. https://doi.org/10.1017/S135561772000106X
   PubMed Web of Science ®Google Scholar
• Baudou, E., Nemmi, F., Biotteau, M., Maziero, S., Peran, P., & Chaix, Y. (2020). Can the cognitive phenotype in neurofibromatosis type 1 (NF1) be explained by neuroimaging? A review. Frontiers of Neurology, 10, 1373. https://doi.org/10.3389/fneur.2019.01373
   PubMed Web of Science ®Google Scholar
• Beaussart, M. L., Barbarot, S., Mauger, C., & Roy, A. (2018). Systematic review and meta-analysis of executive functions in preschool and school-age children with neurofibromatosis type 1. Journal of the International Neuropsychological Society, 24(9), 977–994. https://doi.org/10.1017/S1355617718000383
   PubMed Web of Science ®Google Scholar
• Beaussart-Corbat, M. L., Barbarot, S., Farges, D., Martin, L., & Roy, A. (2021). Executive functions in preschool-aged children with neurofibromatosis type 1: Value for early assessment. Journal of Clinical and Experimental Neuropsychology, 43(2), 163–175. https://doi.org/10.1080/13803395.2021.1893277
   PubMed Web of Science ®Google Scholar
• Benton, A. L., Sivan, A. B., Hamsher, K. D., Varney, N. R., & Spreen, O. (1994). Contributions for neuropsychological assessment (2nd ed.). Psychological Assessment Resources.
   Google Scholar
• Benton, A. L., Varney, N. R., & Hamsher, K. (1976). Judgment of line orientation. Department of Neurology, University of Iowa.
   Google Scholar
• Billingsley, R. L., Jackson, E. F., Slopis, J. M., Swank, P. R., Mahankali, S., & Moore, B. D. (2004). Functional MRI of visual–spatial processing in neurofibromatosis, type I. Neuropsychologia, 42(3), 395–404. https://doi.org/10.1016/j.neuropsychologia.2003.07.008
   PubMed Web of Science ®Google Scholar
• Bulgheroni, S., Taddei, M., Saletti, V., Esposito, S., Micheli, R., & Riva, D. (2019). Visuoperceptual impairment in children with NF1: From early visual processing to procedural strategies. Behavioural Neurology, 2019, 1–10. Article ID 7146168. https://doi.org/10.1155/2019/7146168
   Web of Science ®Google Scholar
• Cardillo, R., Lievore, R., & Mammarella, I. C. (2022). Do children with and without autism spectrum disorder use different visuospatial processing skills to perform the rey–osterrieth complex figure test? Autism Research, 15(7), 1311–1323. https://doi.org/10.1002/aur.2717
   PubMed Web of Science ®Google Scholar
• Chisholm, A. K., Anderson, V., Pride, N. A., Malarbi, S., North, K. N., & Payne, J. M. (2018). Social function and autism spectrum disorder in children and adults with neurofibromatosis type 1: A systematic review and meta-analysis. Neuropsychology Review, 28(3), 317–340. https://doi.org/10.1007/s11065-018-9380-x
   PubMed Web of Science ®Google Scholar
• Clements-Stephens, A. M., Rimrodt, S. L., Gaur, P., & Cutting, L. E. (2008). Visuospatial processing in children with neurofibromatosis type 1. Neuropsychologia, 46(2), 690–697. https://doi.org/10.1016/j.neuropsychologia.2007.09.013
   PubMed Web of Science ®Google Scholar
• Conners, C. K. (1997). Conners’ rating scales-revised. Multi-Health Systems Inc.
   Google Scholar
• Deckersbach, T., Savage, C. R., Henin, A., Mataix-Cols, D., Otto, M. W., Wilhelm, S., Rauch, S. L., Baer, L., & Jenike, M. A. (2000). Reliability and validity of a scoring system for measuring organizational approach in the complex figure test. Journal of Clinical and Experimental Neuropsychology, 22(5), 640–648. https://doi.org/10.1076/1380-3395(200010)22:5;1-9;FT640
   PubMed Web of Science ®Google Scholar
• Descheemaeker, M. J., Ghesquière, P., Symons, H., Fryns, J. P., & Legius, E. (2005). Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children. Journal of Intellectual Disability Research, 49(1), 33–46. https://doi.org/10.1111/j.1365-2788.2005.00660.x
   PubMed Web of Science ®Google Scholar
• Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., & Huson, S. M. (2013). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642–1648. https://doi.org/10.1542/peds.2013-1868
   PubMed Web of Science ®Google Scholar
• Gilboa, Y., Josman, N., Fattal-Valevski, A., Toledano-Alhadef, H., & Rosenblum, S. (2014). Underlying mechanisms of writing difficulties among children with Neurofibromatosis type 1. Research in Developmental Disabilities, 35(6), 1310–1316. https://doi.org/10.1016/j.ridd.2014.03.021
   PubMed Web of Science ®Google Scholar
• Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2000). Behavior rating inventory of executive function: Professional manual. PAR, Inc.
   Google Scholar
• Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J. (2017). Neurofibromatosis type 1. Nature Reviews Disease Primers, 3(1), 17004. https://doi.org/10.1038/nrdp.2017.4
   PubMedGoogle Scholar
• Hirabaru, K., & Matsuo, M. (2018). Neurological comorbidity in children with neurofibromatosis type 1. Pediatrics International, 60(1), 70–75. https://doi.org/10.1111/ped.13388
   PubMed Web of Science ®Google Scholar
• Hyman, S. L., Shores, E. A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65(7), 1037–1044. https://doi.org/10.1212/01.wnl.0000179303.72345.ce
   PubMed Web of Science ®Google Scholar
• Koini, M., Rombouts, S. A. R. B., Veer, I. M., Van Buchem, M. A., & Huijbregts, S. C. J. (2017). White matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control. Brain Imaging and Behavior, 11(6), 1731–1740. https://doi.org/10.1007/s11682-016-9641-3
   PubMed Web of Science ®Google Scholar
• Korkman, M., Kirk, U., & Kemp, S. (1998). A developmental neuropsychological assessment: Manual. Psychological Corporation.
   Google Scholar
• Krab, L. C., Aarsen, F. K., Goede Bolder, A., Catsman-Berrevoets, C. E., Arts, W. F., Moll, H. A., & Elgersma, Y. (2008). Impact of neurofibromatosis type 1 on school performance. Journal of Child Neurology, 23(9), 1002–1010. https://doi.org/10.1177/0883073808316366
   PubMed Web of Science ®Google Scholar
• Krikorian, R., Bartok, J., & Gay, N. (1994). Tower of London procedure: A standard method and developmental data. Journal of Clinical and Experimental Neuropsychology, 16(6), 840–850. https://doi.org/10.1080/01688639408402697
   PubMed Web of Science ®Google Scholar
• Lehtonen, A., Howie, E., Trump, D., & Huson, S. M. (2013). Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence. Developmental Medicine & Child Neurology, 55(2), 111–125. https://doi.org/10.1111/j.1469-8749.2012.04399.x
   PubMed Web of Science ®Google Scholar
• Levine, T. M., Materek, A., Abel, J., O’Donnell, M., & Cutting, L. E. (2006). Cognitive profile of neurofibromatosis type 1. Seminars in Pediatric Neurology, 13(1), 8–20. https://doi.org/10.1016/j.spen.2006.01.006
   PubMedGoogle Scholar
• Meyers, J. E., & Meyers, K. R. (1995). The Meyers scoring system for the Rey complex figure and recognition trial: Professional manual. Psychological Assessment Resources.
   Google Scholar
• Moore, B. (2009). Potential influences on mathematical difficulties in children and adolescents with neurofibromatosis, type 1. Developmental Disabilities Research Reviews, 15(1), 45–51. https://doi.org/10.1002/ddrr.53
   PubMedGoogle Scholar
• Mulder, H., Verhagen, J., Van der Ven, S. H. G., Slot, P. L., & Leseman, P. P. M. (2017). Early executive function at age two predicts emergent mathematics and literacy at age five. Frontiers in Psychology, 8, 1706. https://doi.org/10.3389/fpsyg.2017.01706
   PubMed Web of Science ®Google Scholar
• Osterrieth, P. A. (1944). Le test de copie d’une figure complexe; contribution à l’étude de la perception et de la mémoire. [Test of copying a complex figure; contribution to the study of perception and memory.]. Archives de psychologie, 30, 206–356.
   Google Scholar
• Payne, J. M., Arnold, S. S., Pride, N. A., & North, K. N. (2012). Does attention-deficit–hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1? Developmental Medicine & Child Neurology, 34(10), 898–904. https://doi.org/10.1111/j.1469-8749.2012.04357.x
   Google Scholar
• Payne, J. M., Haebich, K. H., MacKenzie, R., Walsh, K. S., Hearps, S. J. C., Coghill, D., Barton, B., Pride, N. A., Ullrich, N. J., Tonsgard, J. H., Viskochil, D., Schorry, E. K., Klesse, L., Fisher, M. J., Gutmann, D. H., Rosser, T., Packer, R. J., Korf, B., Acosta, M. T., & North, K. N. (2021). Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1. Journal of Attention Disorders, 25(8), 1177–1186. https://doi.org/10.1177/1087054719894384
   PubMed Web of Science ®Google Scholar
• Payne, J. M., Hearps, S. J. C., Walsh, K. S., Paltin, I., Barton, B., Ullrich, N. J., Haebich, K. H., Coghill, D., Gioia, G. A., Cantor, A., Cutter, G., Tonsgard, J., Viskochil, D., Rey-Casserly, C., Schorry, E. K., Ackerson, J. D., Klesse, L., Fisher, M. J., Gutmann, D. H., & North, K. N. (2019). Reproducibility of cognitive endpoints in clinical trials: Lessons from neurofibromatosis type 1. Annals of Clinical & Translational Neurology, 6(12), 2555–2565. https://doi.org/10.1002/acn3.50952
   PubMed Web of Science ®Google Scholar
• Payne, J. M., Hyman, S. L., Shores, E. A., & North, K. N. (2011). Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior. Child Neuropsychology, 17(4), 313–329. https://doi.org/10.1080/09297049.2010.542746
   PubMed Web of Science ®Google Scholar
• Plasschaert, E., Van Eylen, L., Descheemaeker, M. J., Noens, I., Legius, E., & Steyaert, J. (2016). Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 171b(3), 348–362. https://doi.org/10.1002/ajmg.b.32414
   PubMedGoogle Scholar
• Pride, N. A., Korgaonkar, M., North, K. N., Barton, B., & Payne, J. M. (2017). The neural basis of deficient response inhibition in children with neurofibromatosis type 1: Evidence from a functional MRI study. Cortex, 93, 1–11. https://doi.org/10.1016/j.cortex.2017.04.022
   PubMed Web of Science ®Google Scholar
• Pride, N. A., Korgaonkar, M., North, K. N., & Payne, J. M. (2018). Impaired engagement of the ventral attention system in neurofibromatosis type 1. Brain Imaging and Behavior, 12(2), 499–508. https://doi.org/10.1007/s11682-017-9717-8
   PubMed Web of Science ®Google Scholar
• Rance, G., Zanin, J., Maier, A., Chisari, D., Haebich, K. H., North, K. N., Dabscheck, G., Seal, M. L., Delatycki, M. B., & Payne, J. M. (2021). Auditory dysfunction among individuals with neurofibromatosis type 1. JAMA Network Open, 4(12), e2134842. https://doi.org/10.1001/jamanetworkopen.2021.36842
   Web of Science ®Google Scholar
• Rey, A. (1941). L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encephalopathy. Problems.]. Archives de psychologie, 28, 215–285.
   Google Scholar
• Rowbotham, I., Pit ten Cate, I. M., Sonuga-Barke, E. J., & Huijbregts, S. C. (2009). Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology, 23(1), 50–60. https://doi.org/10.1037/a0013927
   PubMed Web of Science ®Google Scholar
• Roy, A., Roulin, J. -L., Charbonnier, V., Allain, P., Fasotti, L., Barbarot, S., Stalder, J. -F., Terrien, A., & Le Gall, D. (2010). Executive dysfunction in children with neurofibromatosis type 1: A study of action planning. Journal of the International Neuropsychological Society, 16(6), 1056–1063.
   PubMed Web of Science ®Google Scholar
• Saxton, R. A., & Sabatini, D. M. (2017). mTOR signaling in growth, metabolism, and disease. Cell, 168(6), 960–976. https://doi.org/10.1016/j.cell.2017.02.004
   PubMed Web of Science ®Google Scholar
• Somerville, J., Tremont, G., & Stern, R. A. (2000). The Boston qualitative scoring system as a measure of executive functioning in rey-osterrieth complex figure performance. Journal of Clinical and Experimental Neuropsychology, 22(5), 613–621. https://doi.org/10.1076/1380-3395(200010)22:5;1-9;FT613
   PubMed Web of Science ®Google Scholar
• Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: administration, norms, and commentary. Oxford University Press.
   Google Scholar
• Ullrich, N. J., Ayr, L., Leaffer, E., Irons, M. B., & Rey-Casserly, C. (2010, October). Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1. Journal of Child Neurology, 25(10), 1195–1202. https://doi.org/10.1177/0883073809358454
   PubMed Web of Science ®Google Scholar
• van der Vaart, T., Rietman, A. B., Plasschaert, E., Legius, E., Elgersma, Y., & Moll, H. A. (2016). Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology, 86(2), 154–160. https://doi.org/10.1212/WNL.0000000000002118
   PubMed Web of Science ®Google Scholar
• Van Eylen, L., Plasschaert, E., Wagemans, J., Boets, B., Legius, E., Steyaert, J., & Noens, I. (2017). Visuoperceptual processing in children with neurofibromatosis type 1: True deficit or artefact? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 174(4), 342–358. https://doi.org/10.1002/ajmg.b.32522
   PubMed Web of Science ®Google Scholar
• Watanabe, K., Ogino, T., Nakano, K., Hattori, J., Kado, Y., Sanada, S., & Ohtsuka, Y. (2005). The rey–osterrieth complex figure as a measure of executive function in childhood. Brain & Development, 27(8), 564–569. https://doi.org/10.1016/j.braindev.2005.02.007
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1991). Wechsler intelligence scale for children (3rd ed.). The Psychological Corporation.
   Google Scholar
• Wechsler, D. (2003). Wechsler intelligence scales for children (4th ed.). The Psychological Corporation.
   Google Scholar
• Zhang, X., Lv, L., Min, G., Wang, Q., Zhao, Y., & Li, Y. (2021). Overview of the complex figure test and its clinical application in neuropsychiatric disorders, including copying and recall. Frontiers in Neurology, 12, 680474. https://doi.org/10.3389/fneur.2021.680474
   PubMed Web of Science ®Google Scholar